Upcoming Investor Conferences for XOMA Royalty Corporation
XOMA Royalty Corporation (NASDAQ: XOMA), a prominent player in the biotechnology royalty sector, is preparing for an eventful September filled with key investor conferences. These gatherings offer the company's Executive Team a chance to connect with potential investors and industry stakeholders, sharing valuable insights and updates.
H.C. Wainwright Annual Global Investment Conference
The first significant event on the calendar is the H.C. Wainwright 26th Annual Global Investment Conference, taking place from September 9-11 in New York City. During this event, Owen Hughes, the Chief Executive Officer, along with Brad Sitko, the Chief Investment Officer, will present a corporate overview. This presentation is set for September 9 at 9:00 AM ET.
How to Access the Presentation
For those interested in attending, the event promises to be highly informative. Additionally, the presentation will be available online, enabling participation from anywhere.
Cantor Global Healthcare Conference
XOMA will also take part in the Cantor Global Healthcare Conference, scheduled for September 17-19. On September 17 at 2:30 PM ET, Mr. Hughes and Mr. Sitko will again present, discussing the company's latest developments and strategic goals.
Accessing Presentations Online
Both presentations can be accessed through XOMA's investor relations webpage. This ensures that those unable to attend in person can still gain insights from the discussions. Furthermore, each presentation will be archived and available for replay for up to 90 days following the events.
About XOMA Royalty Corporation
XOMA Royalty functions as a distinctive biotech royalty aggregator, playing a vital role in promoting health by financially supporting biotechnology companies through the acquisition of future revenue streams from their drug candidates. This model allows sellers to secure non-dilutive funding, enabling them to concentrate on advancing their research initiatives.
Expanding Portfolio
With a diverse and growing collection of assets linked to promising therapeutic candidates, XOMA is well-positioned to make a positive impact in the biotech industry. Investors seeking innovative strategies in biopharmaceutical development often find XOMA's business model particularly attractive.
Contact Information
For further inquiries, XOMA Royalty offers direct contacts for both investor relations and media communications. Juliane Snowden serves as the Investor Contact and can be reached at +1 646-438-9754 or via email at juliane.snowden@xoma.com. For media inquiries, Kathy Vincent from KV Consulting & Management is available at +1 310-403-8951 or kathy@kathyvincent.com.
Frequently Asked Questions
What is XOMA Royalty Corporation?
XOMA Royalty Corporation is a biotech royalty aggregator that assists companies in financing their drug development through innovative financial arrangements.
When will XOMA present at the H.C. Wainwright conference?
XOMA will present on September 9, 2024, at 9:00 AM ET during the H.C. Wainwright Annual Global Investment Conference.
How can I access the presentations?
The presentations will be available on XOMA's investor relations webpage, with archived versions accessible for 90 days after the events.
Who are the key presenters from XOMA?
The presentations will be delivered by Owen Hughes, the CEO, and Brad Sitko, the CIO.
What is the purpose of XOMA's participation in these conferences?
The conferences provide XOMA with an opportunity to share updates on their business strategy and engage with potential investors.
